北京大学学报(医学版) ›› 2015, Vol. 47 ›› Issue (6): 962-965. doi: 10.3969/j.issn.1671167X.2015.06.013

• 论著 • 上一篇    下一篇

强直性脊柱炎合并恶性肿瘤31例

高兰,樊勇,张卓莉△   

  1. (北京大学第一医院风湿免疫科,北京100034)
  • 出版日期:2015-12-18 发布日期:2015-12-18
  • 通讯作者: 张卓莉 E-mail:zhuoli.zhang@126.com

Clinical analysis of 31 ankylosing spondylitis patients with malignancies

GAO Lan, FAN Yong, ZHANG Zhuo-li△   

  1. (Department of Rheumatology and Clinical Immunology, Beijing University First Hospital, Beijing, 100034, China)
  • Online:2015-12-18 Published:2015-12-18
  • Contact: ZHANG Zhuo-li E-mail:zhuoli.zhang@126.com

摘要:

目的:分析强直性脊柱炎患者合并恶性肿瘤的临床特点。方法:选择北京大学第一医院2006年1月至2014年7月明确诊断为强直性脊柱炎合并恶性肿瘤的31例住院患者,与同时期住院的强直性脊柱炎未合并肿瘤患者的临床特点进行比较。并对其一般情况、强直性脊柱炎的临床与影像学表现、肿瘤的特征、预后等进行回顾性分析。结果:31例患者包括男性27例(87%),女性4例(13%),确诊强直性脊柱炎的平均年龄为(43±17)岁(16~76岁);首次确诊肿瘤的平均年龄为(60±12)岁(31~87岁),其中27例患者的肿瘤发生在强直性脊柱炎确诊之后。31例患者确诊强直性脊柱炎时均存在典型的影像学表现,大部分未接受针对强直性脊柱炎的规范化治疗。合并的恶性肿瘤者包括膀胱癌7例,血液系统肿瘤6例,肺癌5例,肾癌5例,前列腺癌、肾盂癌、乳腺癌、胃癌、直肠癌、神经内分泌瘤各2例,结肠癌和食管癌各1例。结论:强直性脊柱炎存在合并恶性肿瘤的风险,以膀胱癌最多见,其次是血液系统肿瘤,临床上需要关注。

关键词: 脊柱炎, 强直性, 肿瘤, 临床特点

Abstract:

Objective:To investigate the clinical features of patients with ankylosing spondylitis (AS) and malignancies.Methods: In the study, 31 AS patients with malignancies in Peking University First Hospital from January 2006 to July 2014 were enrolled, and their clinical features were compared with AS patients without malignancies at the same time in the hospital. Then their general characteristics, clinical and imaging findings of AS, characteristics of malignancies and prognosis were retrospectively analyzed. Results:The 31 cases of AS with malignacies accounted for 11.8% of all AS patients admitted to the hospital in the same period. They comprised of 27 males (87%) and 4 females (13%). Their mean ages at diagnosis of AS were 43±17 years (range: 16-76 years), and their mean ages at diagnosis of malignancy were 60±12 years (range: 31-87 years) respectively. Malignancy was diagnosed after the establishment of AS in 27 of our patients. Furthermore, imaging changes typical of AS were found in all the 31 patients at the diagnosis of AS, but the majority of them had never received any proper treatment for AS. The malignancies of 31 AS patients included bladder cancer (7 cases), hematological malignancy (6 cases), lung cancer (5 cases), renal cancer (5 cases), prostate cancer (2 cases), carcinoma of renal pelvis (2 cases), breast cancer (2 cases), gastric carcinoma (2 cases), rectal cancer (2 cases), neuroendocrine carcinoma (2 cases), colon carcinoma (1 case), and esophagus cancer (1 case).Conclusion:There is risk of malignancy in AS. Malignancy is not rare in patients with AS. Bladder cancer is the most common one followed by hematological malignancy. In consequence, close attention should be paied to the conditon of AS with malignancy in clinical practice.

Key words: Spondylitis, ankylosing, Neoplasms, Clinical features

中图分类号: 

  • R593.23
[1] 季加孚, 韦静涛, 季科, 步召德. 胃癌诊疗的瓶颈与破局:迈向精准化与智能化融合的新纪元[J]. 北京大学学报(医学版), 2026, 58(2): 231-238.
[2] 高加勒, 张忠涛. 局部进展期直肠癌精准治疗现状与展望[J]. 北京大学学报(医学版), 2026, 58(2): 247-250.
[3] 王海, 江一舟. 靶向血管治疗在乳腺癌精准治疗中的分子机制与临床应用[J]. 北京大学学报(医学版), 2026, 58(2): 251-256.
[4] 罗必显, 刘洪铭, 谢伟勋, 龚渭华. 产甲胎蛋白胃癌的新临床特征和前沿科学问题[J]. 北京大学学报(医学版), 2026, 58(2): 257-265.
[5] 杜文, 章文博, 于尧, 刘硕, 苏惠裕, 胡耒豪, 唐祖南, 吴彬彰, 陈震, 李家琦, 王昊, 彭歆. 口腔颌面部肿瘤"数智化外科"诊疗流程探索与临床应用[J]. 北京大学学报(医学版), 2026, 58(2): 278-284.
[6] 王楠楠, 袁大晋, 朱昱冰, 丁磊. 结直肠癌根治术后肝转移风险多中心列线图预测模型的构建与验证[J]. 北京大学学报(医学版), 2026, 58(2): 290-300.
[7] 刘友东, 吕亚军, 陈杰, 臧明德, 潘宏达, 刘晓文, 陆俊, 刘凤林. 全腹腔镜保留贲门胃底胃次全切除术治疗中上部胃癌的疗效及安全性[J]. 北京大学学报(医学版), 2026, 58(2): 301-306.
[8] 李嘉临, 陈力侨, 唐家天, 吴艳, 王安强. 胃肝样腺癌转化治疗1例[J]. 北京大学学报(医学版), 2026, 58(2): 399-404.
[9] 李斌, 梁寒. 机器人胃癌根治术:研究进展与实践挑战[J]. 北京大学学报(医学版), 2026, 58(2): 416-422.
[10] 董海峰, 陈恒星, 张常华. 恶性肿瘤中蛋白质乳酸化修饰的研究进展[J]. 北京大学学报(医学版), 2026, 58(2): 423-430.
[11] 李宏杨, 黄涛, 王琳琳. 脂肪肌肉比率与卵巢良性肿瘤风险的关联性[J]. 北京大学学报(医学版), 2026, 58(1): 169-174.
[12] 高若凡, 马天宇, 王润楷, 殷雨辰, 李芮迪, 王丹丹, 夏斌. 细胞膜囊泡递送靶向肿瘤坏死因子-α的小干扰RNA对牙髓干细胞的抗炎作用[J]. 北京大学学报(医学版), 2026, 58(1): 22-29.
[13] 吴昕峰, 满斯亮, 陈大召, 华勇, 温锡杰, 丁盈月, 张亮, 侯秀娟. 中轴型脊柱关节炎合并髋关节终末期受累的长期影像学参数:单中心24年大样本回顾研究[J]. 北京大学学报(医学版), 2025, 57(6): 1089-1095.
[14] 刘艳华, 陆敏, 赵旭阳, 张宽根, 武睿, 梅放, 戴志豪, 由江峰, 裴斐. 肿瘤转移抑制基因LASS2去磷酸化对液泡型ATP酶活性及前列腺癌侵袭性的影响[J]. 北京大学学报(医学版), 2025, 57(6): 1113-1123.
[15] 杨小勇, 张帆, 马潞林, 刘承. 前列腺导管腺癌临床特征及腺外侵犯的影响因素[J]. 北京大学学报(医学版), 2025, 57(5): 956-960.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!